Tumor-detecting capacity and clinical usefulness of SPIO-MRI in patients with hepatocellular carcinoma

Journal of Gastroenterology

Volumn 35, Issue 11, 2000, Pages 849-855

  Nakamura, Hiroshi ^a   Ito, Naoki ^a   Kotake, Fumio ^a   Mizokami, Yuji ^a   Matsuoka, Takeshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma (HCC); Magnetic resonance imaging (MRI); Superparamagnetic iron oxide (SPIO)

Indexed keywords

GADOLINIUM PENTETATE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR BLOOD FLOW; TUMOR DIFFERENTIATION; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IRON; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033664069     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350070022     Document Type: Article

References (23)

1. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide
2. Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography
3. Detection of liver metastases with superparamagnetic iron oxide in 15 patients: Results of MR imaging at 1.5 T
4. Detection of hepatic metastases: Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging
5. Iron oxide-enhanced MR imaging of the liver and spleen: Review of the first 5 years
6. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging
7. Iron oxide-enhanced MR imaging of hepatocellular carcinoma of woodchuck
8. Hepatic tumors: Comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation
9. Early advanced hepatocellular carcinoma: Evaluation of CT and MR appearance with pathologic correlation
10. Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma
11. Early hepatocellular carcinoma: Appearance at CT during arterial portography and CT arteriography with pathologic correlation
12. Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma
13. The utility of AMI-25 enhanced MRI for HCC
14. Hepatic pseudolesion; appearance of focal low attenuation in the medial segment of the left lobe at CT arterial portography
15. Hepatic parenchymal perfusion defects detected with CTAP: Imaging-pathologic correlation
16. Liver tumors in cirrhosis; experimental study with SPIO-enhanced MR imaging
17. Therapeutic effects of transcatheter arterial embolization using Lipiodol mixed with antitumor agents for small hepatocellular carcinoma
18. Hepatocellular carcinoma after transcatheter hepatic arterial embolization: A histopathologic study of 84 resected cases
19. Hepatocellular carcinoma: Correlation of MR imaging and histopathologic findings
20. Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver
21. Usefulness of superparamagnetic iron oxide particle (AMI-25) enhanced MR imaging for the diagnosis of liver tumors: Comparison with contrast enhanced CT
22. Pathology of human liver tumors
23. Hepatic MRI with SPIO; detection and characterization of focal liver legions